1. In this randomized controlled trial,
medication vouchers were associated with a small increase in
patient-reported persistence with P2Y12 inhibitors for patients who had suffered a myocardial infarction (MI). 2. Medication vouchers were not associated with reduced major adverse
cardiovascular events (MACE) in these patients. Evidence Rating Level: 1 (Excellent) Study Rundown: Antiplatelet therapy, such […]